OPK is reducing debt for BioReference and are estimating profit by end of year . We will see on August 3rd with the ER call . I would not want to be short now with 2 recent milestones payments one from Pfizer and One from Merk $OPK should start to cling back up to $3.00 soon …. And don’t forget NGENLA revenues are going up as well .